文献速递头颈外科咽喉与嗓音

肌少症对头颈癌患者吞咽功能的影响

Effect of Sarcopenia on Swallowing in Patients With Head and Neck Cancer.
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-02-05

这项回顾性队列研究纳入112例头颈癌患者,其中69例(61.6%)在治疗前存在肌少症。肌少症与患者报告吞咽困难风险升高相关(OR=2.71,95%CI 1.12-6.79,P<.05),且是多因素分析中治疗后误吸的独立预测因素(OR=15.18,95%CI 1.50-453.53,P<.05)。

要点

  • 治疗前肌少症与头颈癌患者吞咽困难风险升高相关(OR=2.71,95%CI 1.12-6.79,P<.05)。
  • 肌少症是头颈癌治疗后误吸的独立预测因素(OR=15.18,95%CI 1.50-453.53,P<.05)。
  • 肌少症可通过横断面影像简便测量,可能有助于识别吞咽功能障碍风险患者。

核心结论

  • 治疗前存在肌少症的头颈癌患者治疗前吞咽困难发生率更高,且更可能在完成头颈癌治疗后发生误吸。
  • 肌少症可通过横断面影像简便测量,可能有助于识别吞咽功能障碍风险患者及最可能从预康复中获益者。

研究设计与样本

  • 回顾性队列研究,在学术医疗中心开展,共纳入112例头颈癌患者,其中男性84例(75%)、女性28例(25%)。
  • 治疗前肌少症通过第三颈椎横断面影像计算的骨骼肌指数评估。
  • 采用功能经口摄入量表、进食评估工具-10和穿透-误吸量表分别评估治疗前后的管饲依赖、患者报告吞咽困难和吞咽安全性。

主要发现

  • 112例患者中69例(61.6%)在开始头颈癌治疗前存在肌少症。
  • 肌少症与患者报告吞咽困难风险升高显著相关(OR=2.71,95%CI 1.12-6.79,P<.05)。
  • 多因素逻辑回归显示肌少症是头颈癌治疗后误吸的独立预测因素(OR=15.18,95%CI 1.50-453.53,P<.05)。

临床怎么用

  • 作者认为肌少症可通过横断面影像简便测量,可能有助于识别吞咽功能障碍风险患者及最可能从预康复中获益者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sarcopenia, characterized by decreased skeletal muscle mass, is associated with poorer oncologic outcomes in head and neck cancer (HNC) patients. The effect of sarcopenia on swallowing following HNC treatment is unknown. This study aims to investigate the association of sarcopenia and swallowing dysfunction in patients treated for HNC. STUDY DESIGN: Retrospective cohort study. SETTING: Academic medical center. METHODS: Pretreatment sarcopenia was assessed using the skeletal muscle index calculated from cross-sectional imaging at the third cervical vertebra. Feeding tube dependence, patient-reported dysphagia, and swallowing safety were assessed before and after treatment with the Functional Oral Intake Scale, Eating Assessment Tool-10, and Penetration Aspiration Scale, respectively. The association between sarcopenia and swallowing dysfunction was evaluated. RESULTS: A total of 112 patients were included, 84 males (75%) and 28 females (25%). A total of 69 (61.6%) had sarcopenia prior to initiating HNC therapy. Sarcopenia was significantly associated with an elevated risk of patient-reported dysphagia (odds ratio [OR] = 2.71 [95% confidence interval, CI, 1.12-6.79]; P < .05). Multivariate logistic regression demonstrated that sarcopenia (OR = 15.18 [95% CI, 1.50-453.53]; P < .05) is an independent predictor for aspiration following treatment for HNC. CONCLUSION: Patients with pretreatment sarcopenia had higher rates of dysphagia before treatment and were more likely to develop aspiration after completion of HNC therapy. Sarcopenia is readily measured using cross-sectional imaging and may be useful for identifying patients at risk of swallowing dysfunction and those most likely to benefit from prehabilitation efforts.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Colback AA, Arkfeld DV, Evangelista LM, et al. Effect of Sarcopenia on Swallowing in Patients With Head and Neck Cancer. Otolaryngol Head Neck Surg. 2024. PMID: 38314934. doi:10.1002/ohn.655

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。